Persistent inflammation in the gut, lungs and skin might lead to Alzheimer's disease, but lifestyle choices - from getting ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

A growing body of research points to chronic, low-grade inflammation inside the brain as a possible accelerant of Alzheimer’s disease, not just a bystander response to damage already done. The 2024 ...

A study of 470,000 people reveals that the APOE gene could be behind 90% of Alzheimer's cases in the world today.

Scientists may have discovered a new cause of Alzheimer's disease, which could hold the key to a new treatment. In a new commentary, a team at the University of California, Santa Cruz, argued that ...

A team of scientists examined about 104 people ranging from healthy cognition, mild cognitive impairment to Alzheimer’s disease to identify how eye health can help predict brain disorder.

Researchers engineer CAR-astrocytes to target and remove amyloid plaques in Alzheimer’s, showing a 50% reduction in brain ...

Alzheimer’s Disease scares people, and it should. It is one thing to lose your life – it’s another to lose your mind. Alzheimer’s rates rise with age, and people are living longer. Recent studies show ...

Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...